http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2537146-C1
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_61b58b6690d9688f8fb95ce90d8caeda |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P15-00 |
filingDate | 2013-11-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2014-12-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_70cc0e8c71c9edb548bc21bbd50b3c3a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6239c0ba09b40fa51c175d0b042712d3 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_73dd6a690fcd108c1b76d46858742e8c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_20173cb0e879ecbab9baf31c73a56fb8 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4e81106e9a300d2e93f3fcf1de25eaf3 |
publicationDate | 2014-12-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | RU-2537146-C1 |
titleOfInvention | Agent for treating and preventing endometritis in animals |
abstract | FIELD: medicine. n SUBSTANCE: invention refers to veterinary science, particularly to an agent for treating and preventing endometritis in animals. The substance of the invention consists as follows. Novocaine 0.5 g is dissolved in distilled water 1 l, and the following preparations are dissolved in a solution of Novocaine 250 mg: powdered metronidazole 4.0 g is dissolved in Novocaine 250 ml; powdered ciprofloxacin 2.0 g is dissolved in Novocaine 250 ml; powdered Doxycycline 1.0 g is dissolved in Novocaine 250 ml; powdered tavegil 2.5 g is dissolved in Novocaine 250 ml; all the ingredients are combined to prepare the agent in an amount of 1 litre for treating and preventing endometritis in animals. n EFFECT: invention provides the pronounced anti-inflammatory and antimicrobial effect of a broad spectrum of action combined with reducing the body response to histamine, relieving smooth muscle spasm and reducing capillary penetration. n 5 tbl, 6 ex |
isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2744919-C1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2578464-C1 |
priorityDate | 2013-11-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 46.